Celularity Inc. Costs and Expenses, Related Party
Celularity Inc. (CELU) reported Costs and Expenses, Related Party of $8.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-07-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpensesRelatedParty · last filed 2024-07-30
- Celularity Inc. costs and expenses, related party for fiscal 2022 was $8.00M.
| Period end | Costs and Expenses, Related Party 12 month |
|---|---|
| 2022-12-31 | $8.00M 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |